Hepatosplenic T cell lymphoma epidemiology and demographics

Jump to navigation Jump to search

Hepatosplenic T cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatosplenic T cell lymphoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatosplenic T cell lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatosplenic T cell lymphoma epidemiology and demographics

CDC on Hepatosplenic T cell lymphoma epidemiology and demographics

Hepatosplenic T cell lymphoma epidemiology and demographics in the news

Blogs on Hepatosplenic T cell lymphoma epidemiology and demographics

Directions to Hospitals Treating Hepatosplenic T cell lymphoma

Risk calculators and risk factors for Hepatosplenic T cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Hepatosplenic T cell lymphoma is a common disease that tends to affect young adults and adolescents. Males are more commonly affected with hepatosplenic T cell lymphoma than females.[1]

Epidemiology and Demographics

Age

Hepatosplenic T cell lymphoma is a common disease that tends to affect young adults and adolescents.[1]

Gender

Males are more commonly affected with hepatosplenic T cell lymphoma than females.[1]

References

  1. 1.0 1.1 1.2 Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016


Template:WikiDoc Sources